Dolcas Biotech Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Dolcas Biotech

Access the complete profile.

Dolcas Biotech Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	9 Lenel Rd Landing, NJ 07850

Note: Revenues for privately held companies are statistical evaluations.


Dolcas Biotech's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Dolcas Biotech's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Dolcas Biotech is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Dolcas Biotech Annual Revenue and Growth Rate

Dolcas Biotech	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Dolcas Biotech's revenues are gauged from an analysis of company filings.

Dolcas Biotech's Income Statement (based on Industry Averages)

Dolcas Biotech P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Dolcas Biotech is developing and marketing. Dolcas Biotech's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
VCSR500 Dietary and nutritional supplements; Dietary supplements	09/13/2023
MMP-50 Dietary supplements; Dietary ingredient, namely, green lipped mussel extract for use in the manufacture of dietary supplements; Dietary ingredient, namely, green lipped mussel extract, sold as an integral component of dietary supplements	04/05/2022
TRUOLIV-GOLD Dietary supplements consisting, in substantial part, of a combination of olive leaves, olives, and olive oil	11/19/2021

See all trademarks and details in the Full Report.

Market Share of Dolcas Biotech's Largest Competitors

A competitive analysis shows these companies are in the same general field as Dolcas Biotech, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Dolcas Biotech. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
JAMES ALEXANDER	Blairstown, NJ	100
NVE PHARMACEUTICALS	Andover, NJ	52
TRONEX INTERNATIONAL	Budd Lake, NJ	49
PLX PHARMA	Sparta, NJ	17
DOLCAS BIOTECH	Landing, NJ	5

Future Competition: Dolcas Biotech's Fastest Growing Competitors

These companies are in the same general field as Dolcas Biotech and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)